Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Franck Morschhauser; Martin J.S. Dyer; Harriet S. Walter; Alexey V. Danilov; Loic Ysebaert; Daniel James Hodson; Christopher Fegan; Simon A. Rule; John Radford; Guillaume Cartron; Krimo Bouabdallah; Andrew John Davies; Stephen Spurgeon; Nishanthan Rajakumaraswamy; Biao Li; Rita Humeniuk; Xi Huang; Pankaj Bhargava; Juliane M. Jürgensmeier; Gilles Salles

doi:10.1038/s41375-020-01108-x

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Franck Morschhauser, Martin J.S. Dyer, Harriet S. Walter, Alexey V. Danilov, Loic Ysebaert, Daniel James Hodson, Christopher Fegan, Simon A. Rule, John Radford, Guillaume Cartron, Krimo Bouabdallah, Andrew John Davies, Stephen Spurgeon, Nishanthan Rajakumaraswamy, Biao Li, Rita Humeniuk, Xi Huang, Pankaj Bhargava, Juliane M. Jürgensmeier, Gilles Salles

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Leukemia
DOIs	https://doi.org/10.1038/s41375-020-01108-x
State	Accepted/In press - 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-020-01108-x

Cite this

Morschhauser, F., Dyer, M. J. S., Walter, H. S., Danilov, A. V., Ysebaert, L., Hodson, D. J., Fegan, C., Rule, S. A., Radford, J., Cartron, G., Bouabdallah, K., Davies, A. J., Spurgeon, S., Rajakumaraswamy, N., Li, B., Humeniuk, R., Huang, X., Bhargava, P., Jürgensmeier, J. M., & Salles, G. (Accepted/In press). Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia. https://doi.org/10.1038/s41375-020-01108-x

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. / Morschhauser, Franck; Dyer, Martin J.S.; Walter, Harriet S.; Danilov, Alexey V.; Ysebaert, Loic; Hodson, Daniel James; Fegan, Christopher; Rule, Simon A.; Radford, John; Cartron, Guillaume; Bouabdallah, Krimo; Davies, Andrew John; Spurgeon, Stephen; Rajakumaraswamy, Nishanthan; Li, Biao; Humeniuk, Rita; Huang, Xi; Bhargava, Pankaj; Jürgensmeier, Juliane M.; Salles, Gilles.

In: Leukemia, 2020.

Research output: Contribution to journal › Article › peer-review

Morschhauser, F, Dyer, MJS, Walter, HS, Danilov, AV, Ysebaert, L, Hodson, DJ, Fegan, C, Rule, SA, Radford, J, Cartron, G, Bouabdallah, K, Davies, AJ, Spurgeon, S, Rajakumaraswamy, N, Li, B, Humeniuk, R, Huang, X, Bhargava, P, Jürgensmeier, JM & Salles, G 2020, 'Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma', Leukemia. https://doi.org/10.1038/s41375-020-01108-x

Morschhauser, Franck ; Dyer, Martin J.S. ; Walter, Harriet S. ; Danilov, Alexey V. ; Ysebaert, Loic ; Hodson, Daniel James ; Fegan, Christopher ; Rule, Simon A. ; Radford, John ; Cartron, Guillaume ; Bouabdallah, Krimo ; Davies, Andrew John ; Spurgeon, Stephen ; Rajakumaraswamy, Nishanthan ; Li, Biao ; Humeniuk, Rita ; Huang, Xi ; Bhargava, Pankaj ; Jürgensmeier, Juliane M. ; Salles, Gilles. / Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. In: Leukemia. 2020.

@article{03ab024c3367442cb79c4723c3e8911a,

title = "Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma",

author = "Franck Morschhauser and Dyer, {Martin J.S.} and Walter, {Harriet S.} and Danilov, {Alexey V.} and Loic Ysebaert and Hodson, {Daniel James} and Christopher Fegan and Rule, {Simon A.} and John Radford and Guillaume Cartron and Krimo Bouabdallah and Davies, {Andrew John} and Stephen Spurgeon and Nishanthan Rajakumaraswamy and Biao Li and Rita Humeniuk and Xi Huang and Pankaj Bhargava and J{\"u}rgensmeier, {Juliane M.} and Gilles Salles",

note = "Funding Information: Acknowledgements We extend our thanks to the patients and their families. We would like to thank Jinfeng Liu, Marianna Zavo-dovskaya, and Marina Starodubtseva for support with biomarker analyses. Writing and editorial support was provided by Impact Communication Partners, Inc.",

year = "2020",

doi = "10.1038/s41375-020-01108-x",

language = "English (US)",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

AU - Morschhauser, Franck

AU - Dyer, Martin J.S.

AU - Walter, Harriet S.

AU - Danilov, Alexey V.

AU - Ysebaert, Loic

AU - Hodson, Daniel James

AU - Fegan, Christopher

AU - Rule, Simon A.

AU - Radford, John

AU - Cartron, Guillaume

AU - Bouabdallah, Krimo

AU - Davies, Andrew John

AU - Spurgeon, Stephen

AU - Rajakumaraswamy, Nishanthan

AU - Li, Biao

AU - Humeniuk, Rita

AU - Huang, Xi

AU - Bhargava, Pankaj

AU - Jürgensmeier, Juliane M.

AU - Salles, Gilles

N1 - Funding Information: Acknowledgements We extend our thanks to the patients and their families. We would like to thank Jinfeng Liu, Marianna Zavo-dovskaya, and Marina Starodubtseva for support with biomarker analyses. Writing and editorial support was provided by Impact Communication Partners, Inc.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85097673608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097673608&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-01108-x

DO - 10.1038/s41375-020-01108-x

M3 - Article

AN - SCOPUS:85097673608

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -